Control of B cell development by Ras-mediated activation of Raf

被引:131
|
作者
Iritani, BM
Forbush, KA
Farrar, MA
Perlmutter, RM [1 ]
机构
[1] Univ Washington, Dept Immunol, Seattle, WA 98195 USA
[2] Univ Washington, Dept Biochem Med Med Genet, Seattle, WA 98195 USA
[3] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA
[4] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA
[5] Merck & Co Inc, Merck Sharp & Dohme Res Labs, Rahway, NJ 07065 USA
来源
EMBO JOURNAL | 1997年 / 16卷 / 23期
关键词
B cell development; Raf; Ras; transgenic mice;
D O I
10.1093/emboj/16.23.7019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cell fate commitment in a variety of lineages requires signals conveyed via p21(ras). To examine the role of p21(ras) in the development of B lymphocytes, we generated transgenic mice expressing a dominant-negative form of Ras in B lymphocyte progenitors, using a novel transcriptional element consisting of the E mu enhancer and the lck proximal promoter. Expression of dominant-negative Ras arrests B cell development at a very early stage, prior to formation of the pre-B cell receptor. Furthermore, an activated form of Raf expressed in the same experimental system could both drive the maturation of normal pro-B cells and rescue development of progenitors expressing dominant-negative Ras. Hence p21(ras) normally regulates early development of B lymphocytes by a mechanism that involves activation of the serine/threonine kinase Raf.
引用
收藏
页码:7019 / 7031
页数:13
相关论文
共 50 条
  • [31] Ras-mediated activation of ERK by cisplatin induces cell death independently of p53 in osteosarcoma and neuroblastoma cell lines
    Woessmann, W
    Chen, XB
    Borkhardt, A
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2002, 50 (05) : 397 - 404
  • [32] A BRANCHED SIGNALING PATHWAY FOR NERVE GROWTH-FACTOR IS REVEALED BY SRC-MEDIATED, RAS-MEDIATED, AND RAF-MEDIATED GENE INDUCTIONS
    DARCANGELO, G
    HALEGOUA, S
    MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (06) : 3146 - 3155
  • [33] Ras-mediated activation of ERK by cisplatin induces cell death independently of p53 in osteosarcoma and neuroblastoma cell lines
    Willi Woessmann
    Xinbin Chen
    Arndt Borkhardt
    Cancer Chemotherapy and Pharmacology, 2002, 50 : 397 - 404
  • [34] RAS-mediated nitric oxide signaling in podocytes
    Semenikhina, Marharyta
    Bohovyk, Ruslan
    Klemens, Christine A.
    Russell, Dayvia
    Oates, Jim C.
    Staruschenko, Alexander
    Palygin, Oleg
    FASEB JOURNAL, 2022, 36
  • [35] BCL6 Is Critical to Overcome Oncogene-Induced Senescence in RAS-Mediated B Cell Transformation
    Chan, Lai N.
    Hurtz, Christian
    Xiao, Gang
    Shojaee, Seyedmehdi
    Caeser, Rebecca
    Geng, Huimin
    Melnick, Ari
    Muschen, Markus
    BLOOD, 2016, 128 (22)
  • [36] Signaling pathways in Ras-mediated tumorigenicity and metastasis
    Webb, CP
    Van Aelst, L
    Wigler, MH
    Vande Woude, GF
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (15) : 8773 - 8778
  • [37] Inhibition of Ras-mediated activator protein 1 activity and cell growth by merlin
    Kim, H
    Lim, JY
    Kim, YH
    Kim, H
    Park, SH
    Lee, KH
    Han, H
    Jeun, SS
    Lee, JH
    Rha, HK
    MOLECULES AND CELLS, 2002, 14 (01) : 108 - 114
  • [38] Ras-mediated epigenetic reprogramming: NF-κB-dependent and independent effects
    Durand, Joel
    Baldwin, Albert
    CANCER RESEARCH, 2013, 73
  • [39] Dysfunction of B23/nucleophosmin in Ras-mediated Senescence Cells under Stresses
    Sihn, C.
    Kim, S.
    MOLECULAR BIOLOGY OF THE CELL, 2006, 17
  • [40] An elaborate pathway required for Ras-mediated epigenetic silencing
    Claude Gazin
    Narendra Wajapeyee
    Stephane Gobeil
    Ching-Man Virbasius
    Michael R. Green
    Nature, 2007, 449 : 1073 - 1077